GAVI in talks with China's Sinopharm, other vaccine makers for COVAX doses
- Country:
- Switzerland
The Gavi Vaccine Alliance is in talks with COVID-19 vaccine manufacturers including China's state-owned Sinopharm to expand the COVAX pipeline and secure doses for distribution, a Gavi spokeswoman told Reuters on Monday in response to a query.
Sinopharm received an emergency use listing from the World Health Organization (WHO) last Friday, making it eligible for the COVAX program and bolstering Beijing's push for a bigger role in inoculating the world.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Biotech trade association to split with China's WuXi AppTec
China's foreign minister to visit Australia next week as ties improve
Probe begins after 7 killed, 27 injured in fried chicken shop explosion in China
Taiwan, China dispatch teams to join boat rescue mission near Taiwan-controlled islands
Taiwan, China join rescue mission near sensitive islands